Search Results
78 items found for "RAGE Biotech"
- G.CLIPS biotech is 2 years old this month!
July 2022 " G.CLIPS biotech is 2 years old today🎂. Looking forward for more 🎊 #team #grateful #biotech #work #birthdaycelebration" Read more at the source
- Carola Weiss joins InterAx Biotech AG as VP Business Development
February 2022 "Switzerland Today, InterAx Biotech is pleased to announce that Carola Weiss has joined
- InterAx Biotech AG and Boehringer Ingelheim take collaborate to unlock orphan targets leveraging ...
February 2022 " InterAx Biotech AG and Boehringer Ingelheim take first steps towards collaborating molecule agonists for a challenging orphan GPCR for a highly relevant therapeutic need. 💊 InterAx Biotech #ai #biotech #systemsbiology #drugdiscovery #gpcr #deeptech #orphandrugs #pharma #partnerships #AI4drugdiscovery
- Exscientia welcomes Richard J. Law, as their new Chief Business Officer
the architect behind nearly all of Exscientia's partnerships and collaborations across pharma and #biotech
- GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development
#biotech #lifesciences #appointment #GPCR #Oncology" Read more at the source #DrGPCR #GPCR #IndustryNews
- AELIS PHARMA launches their IPO for €25 million
#IPO #biotech #innovation #traitements #addiction #cannabis #Trisomie21 #Downsyndrome" Read more at the
- Confo Therapeutics receives €1.7 million VLAIO grant for further research on GPCR modulators for ...
2022 Confo Therapeutics receives €1.7 million VLAIO grant for further research on GPCR modulators for rare
- SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...
immunology #antibodies #medicine #cancer #innovation #gpcr #synabs #monoclonalantibodies #drugdiscovery #biotechnology #research #ionchannels #biologics #biotech #pharma #pharmaindustry #pharmaceuticals #oncology #healthcare
- Subscribe to Dr. GPCR Newsletter Today!
Did you know that each month we collect the most recent #GPCR publications and the newest Biotech/Pharma
- Inversago Pharma appoints Glenn S. Vraniak as Chief Financial Officer
(“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, today Vraniak served as Chief Financial Officer of Evaxion Biotech A/S, an AI enabled immuno-oncology company
- 📰 GPCR Weekly News, March 20 to 26, 2023
Industry News Domain Therapeutics was one of the 4 Biotech Trophy nominees at 2023 HealthTech awards. The delisting dilemma: Why do so many biotechs face being kicked off the Nasdaq?. (April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) SLAS Europe 2023 Conference and Exhibition
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
School of Medicine to Receive $3-Million Award from ARPA-H’s Sprint for Women’s Health Nxera Pharma Wins Biotech Year and Financing Deal of the Year at the Citeline Japan Awards 2024 GPCR therapies: Eight promising biotechs
- X4 slashes pipeline, lays off staff just three weeks after netting a $55M PIPE
The Boston biotech revealed Wednesday afternoon that it would downsize its research to focus on its lead
- 📰 GPCR Weekly News, February 6 to 12, 2023
Industry News Biotech startup Structure pulls off rare IPO, raising $161M 3-drug combo leads to 'unprecedented Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) arcoscreen is one of the 13 biotech
- Verily links up with Sosei Heptares for GPCR drug discovery
January 2022 "G-protein-coupled receptors’ star has been on the rise in biotech in recent years as researchers
- Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with ...
fruitful research space has led to more than 700 approved drugs over previous decades—but the two-year-old biotech
- 📰 GPCR Weekly News, April 17 to 23, 2023
pathway of opioid drugs into cellular structures Inversago Pharma will present at BBHIC 2023 Orion Biotechnology attended the Swiss Biotech Day Addex Therapeutics attended the Swiss Biotech Day Sosei Heptares presented
- Third Rock pushes newest fund over $1B line as it marks 15 years in venture capital
That money has gone to some 60 biotechs, much of it as early funding."
- Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B ...
(“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, announced
- 📰 GPCR Weekly News, January 16 to 22, 2023
Joanne Waldstreicher to its Board of Directors GPCR Therapeutics launches multiple myeloma trial Salipro Biotech organized by LINK-J Jounce takes the cash under amended deal with Gilead on anti-CCR8 antibody InterAx Biotech
- 📰 GPCR Weekly News, September 4 to 10, 2023
Our partner, Domain Therapeutics, will attend the SACHS 23rd annual biotech event in Europe. Dr. Therapeutics CEO Pascal Neuville to Discuss Game-Changing GPCR-Targeting Immunotherapies at Sachs Associates' Biotech
- 📰 GPCR Weekly News, January 1 to 7, 2024
Inês Pinheiro and Oliver Hartley from the Orion Biotechnology team on their recent study on Arylsulfatases Enter Agreement for Rhythm to Acquire Global Rights to Oral MC4R Agonist LB54640 Addex to Present at Biotech Conference Isomorphic Labs Announces Strategic Multi-Target Research Collaboration With Novartis Salipro Biotech
- 📰 GPCR Weekly News, May 8 to 14, 2023
Industry News InterAx Biotech to Apply its Leading AI and Cell Signalling Technology to Support Target Validation for a Sosei Heptares GPCR Discovery Program Salipro Biotech and DyNAbind Announce Milestone Clinical Stage X4 Pharmaceuticals Announces Positive Phase 3 Results Showing Mavorixafor Reduced the Rate
- 📰 GPCR Weekly News, October 9 to 15, 2023
Submit a logo design by Nov 1st on the Logo Contest page. Chris Cargill Wins Executive of the Year at the Citeline Pharma Intelligence Awards Japan 2023 Salipro Biotech
- Oxford Professor Of Chemistry And Founder Of Therapeutic Company Wins Two International Awards
prestigious international award – exemplified by the fact that other winners this year are the co-founders of BioNTech
- 📰 GPCR Weekly News, March 27 to April 4, 2023
Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights Salipro Biotech (April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) SLAS Europe 2023 Conference and Exhibition
- 📰 GPCR Weekly News, November 6 to November 12, 2023
You can find more details about the speakers on the Live Talks page, and make sure to mark your calendar Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2023 InterAx Biotech
- 📰 GPCR Weekly News, June 12 to 18, 2023
Pairaudeau, CTO of Exscientia discuss transforming drug discovery using their AI-driven platform Salipro Biotech